Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

Merck, Eisai to shut down late stage trial of liver cancer therapy Pharma News

Merck, Eisai to shut down late stage trial of liver cancer therapy

  • 31 October 2025
  • 1 day ago

Merck Keytruda wins European Commission nod for locally advanced head, neck squamous cell carcinoma Pharma News

Merck Keytruda wins European Commission nod for locally advanced head, neck squamous cell carcinoma

  • 30 October 2025
  • 1 day ago

FDA Expands Indication for Sotatercept-csrk in Pulmonary Arterial Hypertension Pulmonology

FDA Expands Indication for Sotatercept-csrk in Pulmonary Arterial Hypertension

  • 29 October 2025
  • 2 days ago

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension Pharma News

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension

  • 28 October 2025
  • 3 days ago

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer Pharma News

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer

  • 25 October 2025
  • 6 days ago

CDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm Pharma News

CDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm

  • 04 October 2025
  • 3 weeks ago

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants Pharma News

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants

  • 21 September 2025
  • 1 month ago

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval Oncology

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval

  • 20 September 2025
  • 1 month ago

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer Oncology

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer

  • 17 September 2025
  • 1 month ago

Merck KGaA Multiple Sclerosis Drug Fails In Late-Stage Trials Neurology

Merck KGaA Multiple Sclerosis Drug Fails In Late-Stage Trials

  • 04 July 2025
  • 3 months ago

Recent News

Global review links common viral infections to hig...

  • 01 November, 2025

Lower ketone levels and improved exercise capacity...

  • 01 November, 2025

Citrus Flavonoids effective nutritional adjunct to...

  • 01 November, 2025

Daily kimchi intake linked to reduced BMI and bell...

  • 01 November, 2025

Aggressive Risk Factor Management Reduces AF Recur...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.